Samsara Bio Capital, LLC Recursion Pharmaceuticals, Inc. Transaction History

Samsara Bio Capital, LLC

  • $173 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$5.04 - $9.26 $1.37 Million - $2.51 Million
-271,240 Reduced 50.3%
267,996 $2.18 Million
Q4 2021

Feb 14, 2022
SELL
$16.14 - $21.86 $3.45 Million - $4.67 Million
-213,703 Reduced 28.38%
539,236 $9.24 Million
Q3 2021

Nov 15, 2021
SELL
$19.03 - $41.33 $430,915 - $935,876
-22,644 Reduced 2.92%
752,939 $17.3 Million
Q2 2021

Aug 17, 2021
BUY
$18.0 - $37.42 $14 Million - $29 Million
775,583 New
775,583 $28.3 Million

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.12B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email